Citigroup »

Cara Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $38k 51k 0.74
2023-09-30 $75k 45k 1.68
2023-03-31 $346k 71k 4.91
2022-12-31 $796k 74k 10.74
2022-09-30 $685k 73k 9.37
2021-12-31 $995k 82k 12.18
2021-03-31 $141k 6.4k 21.95
2020-12-31 $246k 17k 14.53
2020-09-30 $158k 12k 12.69
2020-06-30 $373k 22k 17.24
2020-03-31 $345k 26k 13.17
2019-12-31 $931k 58k 16.10
2019-09-30 $1.9M 101k 18.29
2019-06-30 $3.8M 175k 21.50
2019-03-31 $1.3M 65k 19.61
2018-12-31 $4.5M 345k 12.99
2018-09-30 $3.9M 164k 23.97
2018-06-30 $1.5M 80k 19.16
2018-03-31 $931k 76k 12.34
2017-12-31 $722k 57k 12.66
2017-09-30 $764k 56k 13.69
2017-06-30 $438k 28k 15.40
2017-03-31 $0 760 0.00
2016-12-31 $5.0k 512 9.77
2016-09-30 $4.0k 512 7.81
2016-06-30 $9.0k 1.9k 4.83
2015-12-31 $164k 9.7k 16.88
2015-09-30 $18k 1.3k 14.14
2015-06-30 $38k 3.1k 12.08
2014-09-30 $2.0k 188 10.64